These findings indicate that IL-2-promotes the activation of IFN-γ production by activated T cells in obese patients and that this pathway may be targeted to overcome γδ T cell dysfunction in obesity. The gene discussed is IL2; the disease is obesity due to melanocortin 4 receptor deficiency.